A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
Clinical trial NCT00002127 · COMPLETED
Trial details
- NCT number
- NCT00002127
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.